Back to Browse Journals » Clinical Interventions in Aging » Volume 3 » Issue 2

Opiates and elderly: Use and side effects

Authors Diane L Chau, Vanessa Walker, Latha Pai, Lwin M Cho

Published Date June 2008 Volume 2008:3(2) Pages 273—278

DOI http://dx.doi.org/10.2147/CIA.S1847

Published 30 June 2008

Diane L Chau1, Vanessa Walker2, Latha Pai3, Lwin M Cho4

University of Nevada School of Medicine, Reno, NV, USA 1Division Geriatric Medicine, 2Internal Medicine, 3Psychiatry, 4Geriatric Medicine, Sierra Nevada Healthcare System, Veterans Affairs Medical Center, Reno, NV, USA

Abstract: The evaluation of pain and the subsequent issue of pain control is a clinical challenge that all healthcare providers face. Pain in the elderly population is especially difficult given the myriad of physiological, pharmacological, and psychological aspects of caring for the geriatric patient. Opiates are the mainstay of pain treatment throughout all age groups but special attention must be paid to the efficacy and side effects of these powerful drugs when prescribing to a population with impaired metabolism, excretion and physical reserve. In a random chart review of 300 US veterans, 44% of those receiving an analgesic also received opioids. The increasing use of opiates for pain management by healthcare practitioners requires that those prescribing opioids be aware of the special considerations for treating the elderly. This article will address the precautions one must take when using opiates in the geriatric population, as well as the side effects and ways to minimize them.

Keywords: opiates, pain, elderly, side effects

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Nanosilver particles in medical applications: synthesis, performance, and toxicity

Ge L, Li Q, Wang M, Ouyang J, Li XJ, Xing MM

International Journal of Nanomedicine 2014, 9:2399-2407

Published Date: 16 May 2014

Effectiveness of preventive home visits in reducing the risk of falls in old age: a randomized controlled trial

Luck T, Motzek T, Luppa M, Matschinger H, Fleischer S, Sesselmann Y, Roling G, Beutner K, König HH, Behrens J, Riedel-Heller SG

Clinical Interventions in Aging 2013, 8:697-702

Published Date: 12 June 2013

NC-6301, a polymeric micelle rationally optimized for effective release of docetaxel, is potent but is less toxic than native docetaxel in vivo

Harada M, Iwata C, Saito H, Ishii K, Hayashi T, Yashiro M, Hirakawa K, Miyazono K, Kato Y, Kano MR

International Journal of Nanomedicine 2012, 7:2713-2727

Published Date: 31 May 2012

Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment

Tang J, Xu N, Ji H, Liu H, Wang Z, Wu L

International Journal of Nanomedicine 2011, 6:2429-2435

Published Date: 19 October 2011

Once-daily treatment of ADHD with guanfacine: patient implications

Brandon C Strange

Neuropsychiatric Disease and Treatment 2008, 4:499-506

Published Date: 30 June 2008

Osteoporosis screening and risk management

Consuelo H Wilkins

Clinical Interventions in Aging 2007, 2:389-394

Published Date: 8 October 2007